UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Innate immune dysfunction in inflammatory bowel disease

Journal of internal medicine, 2012-05, Vol.271 (5), p.421-428

2012

Volltextzugriff (PDF)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Volltextzugriff (PDF)

Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2

Clinical and experimental immunology, 2008-03, Vol.151 (3), p.528-535

2008

Volltextzugriff (PDF)

European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis

Gut, 2006-03, Vol.55 (suppl 1), p.i1-i15

2006

Volltextzugriff (PDF)

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Gut, 2006-03, Vol.55 (suppl 1), p.i16-i35

2006

Volltextzugriff (PDF)

Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients

Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (1), p.129-136

2013

Volltextzugriff (PDF)

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

Gut, 2004-11, Vol.53 (11), p.1658-1664

2004

Volltextzugriff (PDF)

European evidence-based Consensus on the management of ulcerative colitis: Current management

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.24-62

2008

Volltextzugriff (PDF)

Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus

Alimentary pharmacology & therapeutics, 2010-05, Vol.31 (9), p.1036-1041

2010

Volltextzugriff (PDF)

Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments

Proceedings of the National Academy of Sciences - PNAS, 2019-02, Vol.116 (9), p.3746-3751

2019

Volltextzugriff (PDF)

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)

The American journal of gastroenterology, 1998-10, Vol.93 (10), p.1860-1866

1998

Volltextzugriff (PDF)

ABCB1 Single‐Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

Clinical pharmacology and therapeutics, 2011-03, Vol.89 (3), p.422-428

2011

Volltextzugriff (PDF)

Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease

Alimentary pharmacology & therapeutics, 2009-09, Vol.30 (6), p.621-633

2009

Volltextzugriff (PDF)

Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status

Journal of clinical pathology, 2003-05, Vol.56 (5), p.352-357

2003

Volltextzugriff (PDF)

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and colitis, 2009-06, Vol.3 (2), p.47-91

2009

Volltextzugriff (PDF)

Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide

Mucosal immunology, 2015-05, Vol.8 (3), p.661-671

2015

Volltextzugriff (PDF)

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 Versus prednisolone in active crohn's disease

The American journal of gastroenterology, 2006-04, Vol.101 (4), p.793-797

2006

Volltextzugriff (PDF)

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.1-23

2008

Volltextzugriff (PDF)

Decreased Paneth cell defensin expression in ileal Crohn’s disease is independent of inflammation, but linked to the NOD2 1007fs genotype

Gut, 2009-06, Vol.58 (6), p.882-3; discussion 883-4

2009

Volltextzugriff (PDF)

6‐Thioguanine — efficacy and safety in chronic active Crohn's disease

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (4), p.503-508

2003

Volltextzugriff (PDF)

Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease

Mucosal immunology, 2008-11, Vol.1 (1s), p.S67-S74

2008

Volltextzugriff (PDF)

Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission

The American journal of gastroenterology, 2002-02, Vol.97 (2), p.377-381

2002

Volltextzugriff (PDF)

Synergistic Sedation with Low-Dose Midazolam and Propofol for Colonoscopies

Endoscopy, 2000-03, Vol.32 (3), p.239-244

2000

Volltextzugriff (PDF)

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2000-02, Vol.14 (2), p.171-176

2000

Volltextzugriff (PDF)

Innate immunity and colonic inflammation: Enhanced expression of epithelial α-defensins

Digestive diseases and sciences, 2002-06, Vol.47 (6), p.1349-1355

2002

Volltextzugriff (PDF)

1 – 25 von 563

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(476)
Mit Volltextzugriff
(385)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(277)
Humans
(256)
Life Sciences & Biomedicine
(248)
Gastroenterology & Hepatology
(118)
Biological And Medical Sciences
(114)
Male
(112)
Female
(98)
Medical Sciences
(87)
Adult
(84)
Middle Aged
(68)
Animals
(67)
Aged
(49)
Gastroenterology. Liver. Pancreas. Abdomen
(41)
Pharmacology. Drug Treatments
(35)
Other Diseases. Semiology
(34)
Inflammatory Bowel Disease
(33)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(33)
Crohn Disease - Drug Therapy
(32)
Crohn's Disease
(32)
General & Internal Medicine
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Innate immune dysfunction in inflammatory bowel disease

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2

European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

European evidence-based Consensus on the management of ulcerative colitis: Current management

Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus

Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)

ABCB1 Single‐Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease

Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 Versus prednisolone in active crohn's disease

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

Decreased Paneth cell defensin expression in ileal Crohn’s disease is independent of inflammation, but linked to the NOD2 1007fs genotype

6‐Thioguanine — efficacy and safety in chronic active Crohn's disease

Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease

Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission

Synergistic Sedation with Low-Dose Midazolam and Propofol for Colonoscopies

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

Innate immunity and colonic inflammation: Enhanced expression of epithelial α-defensins

Suchergebnisse filtern